1. Home
  2. ELSE vs IMNN Comparison

ELSE vs IMNN Comparison

Compare ELSE & IMNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Electro-Sensors Inc.

ELSE

Electro-Sensors Inc.

HOLD

Current Price

$4.43

Market Cap

15.4M

Sector

Industrials

ML Signal

HOLD

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$3.17

Market Cap

11.5M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELSE
IMNN
Founded
1968
1982
Country
United States
United States
Employees
N/A
N/A
Industry
Industrial Machinery/Components
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
15.4M
11.5M
IPO Year
1995
2000

Fundamental Metrics

Financial Performance
Metric
ELSE
IMNN
Price
$4.43
$3.17
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.00
AVG Volume (30 Days)
4.0K
71.9K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.09
N/A
Revenue
$10,142,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$49.17
N/A
Revenue Growth
8.20
N/A
52 Week Low
$3.65
$0.37
52 Week High
$5.29
$9.32

Technical Indicators

Market Signals
Indicator
ELSE
IMNN
Relative Strength Index (RSI) 52.07 56.50
Support Level $4.21 $3.00
Resistance Level $4.45 $3.24
Average True Range (ATR) 0.08 0.19
MACD 0.00 0.03
Stochastic Oscillator 62.12 90.71

Price Performance

Historical Comparison
ELSE
IMNN

About ELSE Electro-Sensors Inc.

Electro-Sensors Inc manufactures and sells industrial production monitoring and process control systems. It manufactures a complete line of monitoring and control systems for a wide range of industrial machine applications. The systems measure machine production and operation rates, as well as regulate the speed of related machines in production processes. Its products include motor drive control, position monitors, sensor targets, signal conditioners, speed sensors, speed switches, tachometers, temperature sensors, vibration monitors, etc.

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

Share on Social Networks: